SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001193125-16-510440
Filing Date
2016-03-18
Accepted
2016-03-18 16:47:37
Documents
5
Period of Report
2016-03-18

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY MERGER PROXY STATEMENT d159357dprem14a.htm PREM14A 2352414
2 GRAPHIC g159357g11y19.jpg GRAPHIC 66558
3 GRAPHIC g159357g87h06.jpg GRAPHIC 73589
4 GRAPHIC g159357page_1.jpg GRAPHIC 112983
5 GRAPHIC g159357page_2.jpg GRAPHIC 85224
  Complete submission text file 0001193125-16-510440.txt   2819498
Mailing Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025 650-272-6269
Avalanche Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-36579 | Film No.: 161516589
SIC: 2836 Biological Products, (No Diagnostic Substances)